来自MSN3 个月
TARA Stock Soars on Superior Efficacy of Bladder Cancer Cell Therapy
In the proof-of-concept cohort involving BCG-naïve patients ... Protara’s clinical pipeline comprises an investigational IV phospholipid substrate replacement therapy, IV Choline Chloride ...